Literature DB >> 22282405

A Classification Approach for Risk Prognosis of Patients on Mechanical Ventricular Assistance.

Yajuan Wang1, Carolyn Penstein Rosé, Antonio Ferreira, Dennis M McNamara, Robert L Kormos, James F Antaki.   

Abstract

The identification of optimal candidates for ventricular assist device (VAD) therapy is of great importance for future widespread application of this life-saving technology. During recent years, numerous traditional statistical models have been developed for this task. In this study, we compared three different supervised machine learning techniques for risk prognosis of patients on VAD: Decision Tree, Support Vector Machine (SVM) and Bayesian Tree-Augmented Network, to facilitate the candidate identification. A predictive (C4.5) decision tree model was ultimately developed based on 6 features identified by SVM with assistance of recursive feature elimination. This model performed better compared to the popular risk score of Lietz et al. with respect to identification of high-risk patients and earlier survival differentiation between high- and low- risk candidates.

Entities:  

Year:  2010        PMID: 22282405      PMCID: PMC3265358          DOI: 10.1109/ICMLA.2010.50

Source DB:  PubMed          Journal:  Proc Int Conf Mach Learn Appl


  8 in total

1.  Long-term use of a left ventricular assist device for end-stage heart failure.

Authors:  E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier
Journal:  N Engl J Med       Date:  2001-11-15       Impact factor: 91.245

2.  Pre-operative prediction of post-VAD implant mortality using easily accessible clinical parameters.

Authors:  Stefan Klotz; Christian Vahlhaus; Christian Riehl; Christiane Reitz; Juergen R Sindermann; Hans H Scheld
Journal:  J Heart Lung Transplant       Date:  2009-09-26       Impact factor: 10.247

3.  Combining multiple models to generate consensus: application to radiation-induced pneumonitis prediction.

Authors:  Shiva K Das; Shifeng Chen; Joseph O Deasy; Sumin Zhou; Fang-Fang Yin; Lawrence B Marks
Journal:  Med Phys       Date:  2008-11       Impact factor: 4.071

4.  The Seattle Heart Failure Model: prediction of survival in heart failure.

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; Santosh C Sutradhar; Stefan D Anker; Anne B Cropp; Inder Anand; Aldo Maggioni; Paul Burton; Mark D Sullivan; Bertram Pitt; Philip A Poole-Wilson; Douglas L Mann; Milton Packer
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

5.  Can the Seattle heart failure model be used to risk-stratify heart failure patients for potential left ventricular assist device therapy?

Authors:  Wayne C Levy; Dariush Mozaffarian; David T Linker; David J Farrar; Leslie W Miller
Journal:  J Heart Lung Transplant       Date:  2009-03       Impact factor: 10.247

6.  Evaluation of risk indices in continuous-flow left ventricular assist device patients.

Authors:  Justin M Schaffer; Jeremiah G Allen; Eric S Weiss; Nishant D Patel; Stuart D Russell; Ashish S Shah; John V Conte
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

Review 7.  Destination therapy: current results and future promise.

Authors:  Katherine Lietz; Leslie W Miller
Journal:  Semin Thorac Cardiovasc Surg       Date:  2008

8.  Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.

Authors:  Katherine Lietz; James W Long; Abdallah G Kfoury; Mark S Slaughter; Marc A Silver; Carmelo A Milano; Joseph G Rogers; Yoshifumi Naka; Donna Mancini; Leslie W Miller
Journal:  Circulation       Date:  2007-07-16       Impact factor: 29.690

  8 in total
  4 in total

1.  A new Bayesian network-based risk stratification model for prediction of short-term and long-term LVAD mortality.

Authors:  Natasha A Loghmanpour; Manreet K Kanwar; Marek J Druzdzel; Raymond L Benza; Srinivas Murali; James F Antaki
Journal:  ASAIO J       Date:  2015 May-Jun       Impact factor: 2.872

Review 2.  Personalized cardiovascular medicine: concepts and methodological considerations.

Authors:  Henry Völzke; Carsten O Schmidt; Sebastian E Baumeister; Till Ittermann; Glenn Fung; Janina Krafczyk-Korth; Wolfgang Hoffmann; Matthias Schwab; Henriette E Meyer zu Schwabedissen; Marcus Dörr; Stephan B Felix; Wolfgang Lieb; Heyo K Kroemer
Journal:  Nat Rev Cardiol       Date:  2013-03-26       Impact factor: 32.419

3.  A Bayesian Model to Predict Right Ventricular Failure Following Left Ventricular Assist Device Therapy.

Authors:  Natasha A Loghmanpour; Robert L Kormos; Manreet K Kanwar; Jeffrey J Teuteberg; Srinivas Murali; James F Antaki
Journal:  JACC Heart Fail       Date:  2016-06-08       Impact factor: 12.035

4.  Cardiac Health Risk Stratification System (CHRiSS): a Bayesian-based decision support system for left ventricular assist device (LVAD) therapy.

Authors:  Natasha A Loghmanpour; Marek J Druzdzel; James F Antaki
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.